|
DCTN6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.519400E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.65009999997245E-06 |
| Normal-vs-Stage2 |
8.518000E-02 |
| Normal-vs-Stage3 |
7.809000E-01 |
| Normal-vs-Stage4 |
1.694830E-01 |
| Stage1-vs-Stage2 |
5.881200E-01 |
| Stage1-vs-Stage3 |
1.004020E-04 |
| Stage1-vs-Stage4 |
2.49630000004331E-06 |
| Stage2-vs-Stage3 |
6.336300E-02 |
| Stage2-vs-Stage4 |
1.760090E-02 |
| Stage3-vs-Stage4 |
3.615200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.156600E-03 |
| Normal-vs-AfricanAmerican |
2.865400E-01 |
| Normal-vs-Asian |
4.354400E-01 |
| Caucasian-vs-AfricanAmerican |
5.348200E-01 |
| Caucasian-vs-Asian |
1.894200E-01 |
| AfricanAmerican-vs-Asian |
1.865360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.496300E-02 |
| Normal-vs-Female |
2.255700E-03 |
| Male-vs-Female |
8.301900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.714000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.479600E-03 |
| Normal-vs-Age(61-80Yrs) |
7.578200E-02 |
| Normal-vs-Age(81-100Yrs) |
2.936400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.125200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.427000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.032600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.319200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.786800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.729600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.75979999999365E-05 |
| Normal-vs-Grade 2 |
6.10660000011087E-07 |
| Normal-vs-Grade 3 |
3.754200E-01 |
| Normal-vs-Grade 4 |
1.416350E-03 |
| Grade 1-vs-Grade 2 |
2.184500E-02 |
| Grade 1-vs-Grade 3 |
5.56309999999449E-05 |
| Grade 1-vs-Grade 4 |
7.64159999722125E-08 |
| Grade 2-vs-Grade 3 |
9.69659999999761E-05 |
| Grade 2-vs-Grade 4 |
7.5201000981906E-10 |
| Grade 3-vs-Grade 4 |
1.552810E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.63657976059994E-12 |
| Normal-vs-ccB subtype |
4.436500E-03 |
| ccA subtype-vs-ccB subtype |
1.62447832963153E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.216400E-02 |
| Normal-vs-N1 |
4.324300E-02 |
| N0-vs-N1 |
1.172060E-02 |
|
|
